← Back to Dashboard

Dovato

Integrase strand transfer inhibitor + NRTI

Constituent drugs (2)

Dolutegravir

Could not render structureView on PubChem
3D not available

Lamivudine

Could not render structureView on PubChem
3D not available

Chemical Identifiers

ClinicalTrials.govPubMed

Clinical Development by Virus1

Human immunodeficiency virus 1
HIV-1
Target: Viral integrase + RT
Approved (other)
Preclinical
Phase 2positive
Phase 3positive
Approved
Japan
Approval ref (pmda.go.jp) PMDA approved Jan. 14, 2020fixed-dose combination of Dolutegravir, Lamivudine.